Shree Ganesh Biotech (India) Ltd - 539470 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Krishna Corporation Shree Ganesh Biotech (India) Ltd - 539470 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Krishna Corporation Shree Ganesh Biotech (India) Ltd - 539470 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shiv Shakti Investment Shree Ganesh Biotech (India) Ltd - 539470 - Reg. 34 (1) Annual Report.
Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial year 2022-23 along with the Notice of 13th Annual General Meeting to be held on Thursday 28th September, 2023. Thanking you. Thanking you. Shree Ganesh Biotech (India) Ltd - 539470 - Board Meeting Outcome for Un-Audited Financial Result Quarter Ending 30Th June, 20223 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015.
Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Monday 14th August 2023 at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter ended as on 30th June, 2023. The board meeting started on 03.30 P.M and concluded on 04.00. P.M Please take the above intimation in your records. Thanking You.